2m 2m 2m 2m 2m 2m 2m
ENSYSCE BIO (ENSC)
NASDAQ
$0.37-$0.006 (-1.69%)
Price as of Aug 21, 2026 7:41 PM EDT- $7.3MMarket Cap
- -81.79%1-Year Change
- BiotechnologyIndustry
ENSYSCE BIO (ENSC)
$0.37-$0.006 (-1.69%)
ENSC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.37 | ||
Change | -$0.004 (-1.19%) | ||
Open | $0.37 | ||
High | $0.37 | ||
Low | $0.36 | ||
Previous Close | $0.38 | ||
Volume | 778,161 | ||
30-Day Average Volume | 37,760,785 | ||
1-Week Change | -6.65% | ||
1-Month Change | 30.39% | ||
1-Year Change | -81.79% | ||
3-Year Change | -98.72% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 19.5M | ||
Total Assets | $3.0M | ||
Market Cap | $7.3M | ||
Enterprise Value | $7.0M | ||
Period: QTR TTM FY | |||
Revenue | $1.2M | ||
Net Income | -$2.6M | ||
Free Cash Flow | -$2.0M | ||
EBIT | -$2.6M | ||
EBITDA | -$2.6M | ||
Net Working Capital | -$1.2M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 6 | ||
P/B | -9 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 12/06/2024 | ||
Earnings & Revenue